These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 32487621)

  • 1. Investigation of the Effects of MicroRNA-221 Expression Levels in Glioblastoma Multiforme Tumors.
    Ozdogan S; Yaltirik CK; Yilmaz SG; Akdeniz FT; Sumerkent K; Duzkalir AH; Ture U; Isbir T
    Anticancer Res; 2020 Jun; 40(6):3265-3270. PubMed ID: 32487621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.
    Herman A; Gruden K; Blejec A; Podpečan V; Motaln H; Rožman P; Hren M; Zupančič K; Veber M; Verbovšek U; Lah Turnšek T; Porčnik A; Koršič M; Knežević M; Jeras M
    PLoS One; 2015; 10(5):e0125791. PubMed ID: 25950799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform.
    Swellam M; Ezz El Arab L; Al-Posttany AS; B Said S
    J Neurooncol; 2019 Sep; 144(3):545-551. PubMed ID: 31422498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme.
    Sippl C; Ketter R; Braun L; Teping F; Schoeneberger L; Kim YJ; List M; Nakhoda A; Wemmert S; Oertel J; Urbschat S
    Acta Neurochir (Wien); 2019 Nov; 161(11):2299-2309. PubMed ID: 31478117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
    Wang Q; Li P; Li A; Jiang W; Wang H; Wang J; Xie K
    J Exp Clin Cancer Res; 2012 Nov; 31(1):97. PubMed ID: 23174013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
    Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW
    Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNA is a biomarker for post-operative monitoring in glioma.
    Morokoff A; Jones J; Nguyen H; Ma C; Lasocki A; Gaillard F; Bennett I; Luwor R; Stylli S; Paradiso L; Koldej R; Paldor I; Molania R; Speed TP; Webb A; Infusini G; Li J; Malpas C; Kalincik T; Drummond K; Siegal T; Kaye AH
    J Neurooncol; 2020 Sep; 149(3):391-400. PubMed ID: 32915353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
    Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.
    Yan W; Li R; Liu Y; Yang P; Wang Z; Zhang C; Bao Z; Zhang W; You Y; Jiang T
    Oncotarget; 2014 Dec; 5(24):12908-15. PubMed ID: 25415048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA as potential biomarkers in Glioblastoma.
    Areeb Z; Stylli SS; Koldej R; Ritchie DS; Siegal T; Morokoff AP; Kaye AH; Luwor RB
    J Neurooncol; 2015 Nov; 125(2):237-48. PubMed ID: 26391593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances of the regulation roles of MicroRNA in glioblastoma.
    Yan C; Kong X; Gong S; Liu F; Zhao Y
    Int J Clin Oncol; 2020 Jul; 25(7):1215-1222. PubMed ID: 32347433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
    Nayak S; Aich M; Kumar A; Sengupta S; Bajad P; Dhapola P; Paul D; Narta K; Purkrait S; Mehani B; Suri A; Chakraborty D; Mukhopadhyay A; Sarkar C
    Sci Rep; 2018 May; 8(1):7673. PubMed ID: 29769662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma.
    Tang H; Liu Q; Liu X; Ye F; Xie X; Xie X; Wu M
    J Cancer Res Ther; 2015; 11(3):630-4. PubMed ID: 26458593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.
    Ilhan-Mutlu A; Wöhrer A; Berghoff AS; Widhalm G; Marosi C; Wagner L; Preusser M
    J Neurooncol; 2013 May; 112(3):347-54. PubMed ID: 23420397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
    Chan JA; Krichevsky AM; Kosik KS
    Cancer Res; 2005 Jul; 65(14):6029-33. PubMed ID: 16024602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.